Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Sleep Wake Disorders: full-pipeline trial registry
5 of 7 indexed Sleep Wake Disorders trials are currently recruiting.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Sleep Wake Disorders: 7 US clinical trials tracked, 5 recruiting.
Sleep Wake Disorders is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Vanda Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition sleep-wake-disorders
OPEN 5 | RECR 71% | LATE 1 | EARLY 1 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)
Sleep Wake Disorders lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Sleep Wake Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Sleep Wake Disorders is recruiting above its size-band peers.
5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Sleep Wake Disorders trials is spread across many organizations.
Vanda Pharmaceuticals accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Sleep Wake Disorders trials plan to enrol fewer than 100 people.
Median target enrolment is 70 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
Sleep Wake Disorders research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
State University of New York - Upstate Medical University
NCT05012605
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
University of Virginia
NCT05565833
Mind After Midnight
University of Arizona
NCT07438912
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Vanda Pharmaceuticals
NCT04652882
Biomarkers of Increased Free Living Sleep Time
University of Utah
NCT04214184
PSG Validation Study of Zensorium Biosensing Wearable Device
University of California, San Diego
NCT04200495
Biomarkers of Insufficient Sleep and Sleepiness
University of Colorado, Boulder
NCT03130803
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Sleep Wake Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Sleep Wake Disorders trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Sleep Wake Disorders page
7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Sleep Wake Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Vanda Pharmaceuticals sponsors the most Sleep Wake Disorders trials on record, review their full trial history before evaluating a specific study. See Vanda Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sleep Wake Disorders condition card totals 7 registered trials; most-linked intervention Insufficient Sleep; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.